Hepatitis viral C in kidney transplantation: Comparative study between two Maghrebin centers: Casablanca and Tunis;L'hépatite virale C au cours de la transplantation rénale: Étude comparative entre deux centres Maghrébins: Casablanca et Tunis

Tunisie Medicale

Volumn 88, Issue 12, 2010, Pages 902-909

  Lakhoua Gorgi, Yousr ^a   Gorgi, Farah ^a   Madkouri, Ghislen ^b   Abderrahim, Ezzeddine ^a   Sfar, Imen ^a   Ramadani, Benyounes ^b   Aouadi, Houda ^a   Jendoubi Ayed, Saloua ^a   Ben Abdallah, Taïeb ^a   Ayed, Khaled ^a  

^a CHARLES NICOLLE HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Hemodialysis; Hepatitis viral C; Kidney transplantation

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CHRONIC GRAFT REJECTION; CONTAMINATION; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORBIDITY; MOROCCO; MORTALITY; PERITONEAL DIALYSIS; PROTEINURIA; RECIPIENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; TUNISIA;

ADOLESCENT; ADULT; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MOROCCO; PREVALENCE; TUNISIA; YOUNG ADULT;

EID: 78650858487     PISSN: 00414131     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Fishman JA, Rubin RH. Infection in organ transplant recipients. Medical Progress 1998; 338: 1741-51.
2. Rubin RH. Infections disease complications of renal transplantation. Kidney Int 1993; 44: 221-36.
3. Gane E. Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 2002; 74: 427-37. (Pubitemid 34977668)
4. Pol S, Legendre C. Viral hepatitis in hemodialysis and renal transplantation patients. Nephrologie 1994;15:191-5.
5. Chan TM, Lok ASF, Cheng IKP, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993; 104: 862-8.
6. Favero MS, Alter MJ, Bland LA. Nosocomial infections associated with hemodialysis. In Mayhall, Hospital Epidemiology and Infection Control, 1st edition 1996; 693-714.
7. Pol S, Debure A, Degott C, et al. Chronic hepatitis in kidney allograft recipients. Lancet 1990; 335: 878-80.
8. Gallego E, Lopez A, Perez J, et al. Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis. Nephron Clin Pract. 2006; 104:1-6.
9. Trépo C, Merle P, Zoulin F. Hépatites virales B et C dans Pathologie Science 2006. Edition: John Libbey.
10. Pedroso S, Martins L, Fonseca I, et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc 2006; 38:1890-4. (Pubitemid 44190078)
11. Seth AK, Anand AC, Gedela SP, Baliga KV. Rapid progression of hepatitis C-induced liver failure in renal allograft recipients. Indian J Gastroenterol 2006; 25:155-6.
12. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N. Chronic hepatitis C infection in renal transplant: treatment and outcome. Clin Transplant 2006; 20: 677-83.
13. Carbognin SJ, Solomon NM, Yeo FE, et al. Acute renal allograft rejection following pegylated IFN-alpha treatment for chronic HCV in a repeat allograft recipient on hemodialysis: a case report. Am J Transplant 2006; 6:1746-51.
14. Desenclos JC. L'infection par le virus de l'hépatite C dans le monde: importance en santé publique, modes de transmission et perspectives. Virologie 2003; 7: 177-92.
15. Lindsay KL, El-Shahawy M, Milstein S, et al. HCV RNA levels are lowered during hemodialysis in patients with HCV chronic hepatitis C. Hepatology (abstract) 1994; 20:239A.
16. Fabrizi F, Lunghi G, Marai P, et al. Virological and histological features of hepatitis C (HCV) infection in kidney transplant recipients. Nephrol Dial Transplant 1996; 11: 159-64.
17. Roth D, Zucker K, Cirocco R, et al. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238-44. (Pubitemid 24046014)
18. Thierry N, Sylvie R, François D. Epidémiologie de l'hépatite C en Afrique. Gastroentérol Clin Biol 1997; 21 :596-606.
19. Benamar L, Rhou H, Ezzaitouni F, et al. Hépatite virale C chez les hémodialysés chroniques au CHU de Rabat, prevalence et facteurs de risqué. Médecine du Maghreb 2001; 89 :17-20.
20. Ayed K, Gorgi Y, Ben Abdallah T, et al. Hepatitis C virus infection in hemodialysis patients from Tunisia: national survey by serologic and molecular methods. Transplant Proc 2003; 35: 2573-75. (Pubitemid 37378068)
21. Cassidy MJD, Jankelson D, Becker M, Moosa R. Hepatitis C and hemodialysis : more evidence for nosocomial spread. International association of nephrology (abstract). Jerusalem 1993; 392.
22. Dussol B, Berthezene P, Bruet PH, Roubicek C, Berland Y. Hepatitis C among chronique dialysis patients in South of France. Am J of Kidney Diseases 1995; 25: 399-404.
23. Kuhns M, De Medina M, Mc Namara A, et al. Detection of hepatitis C virus RNA in hemodialysis patients. J Am Soc Nephrol 1994; 4: 1491-97.
24. Huraib S, Alrasheed R, Aldrees A, Aljefry M, Hrif M, Faieh FA. High prevalence and risk factors for hepatitis C in Saudi Arabia: a need for new strategies in dialysis practice. Nephrol Dial Transplant 1995; 10: 470-74.
25. Dhumeaux D, Marcellin P, Lerebours E. Treatment of hepatitis C. The 2002 French Consensus. Gut 2003; 52: 1784-7.
26. Feray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology 1995; 108: 1088-96.
27. Silini E, Bottelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A case-control study. Gastroenterology 1996; 111: 199-205.
28. Romeo R, Tommasini M, Rumi M, et al. Genotypes in the progression of hepatitis C related cirrhosis and development of hepatocellular carcinoma (abstract). Hepatology 1996; 24: 153A:108.
29. Yamada M, Kakumu S, Yoshioka K, Higashi Y, Tanaka K, Ishikawa T. Hepatitis C virus genotypes are not responsible for development of serious liver diseases. Dig Dis Sci 1994; 39: 234-9.
30. Cantu P, Mangano S, Masini M, Limido A, Crovetti G, Defilippo C. Prevalence of antibodies against hepatitis C virus in a dialysis unit. Nephron 1992; 61: 337-8.
31. Cendoroglo-Neto M, Draibe SA, Silva AE et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: Evidence for environnemental transmission. Nephrol Dial Transplant 1995; 10: 240-6.
32. Huang CC, Wu MS, Lin DY, Liaw YF. The prevalence of hepatitis C virus antibodies in patients treated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1992; 12: 31-33.
33. Selgas R, Martinez-Zapico R, Bajo MA et al. Prevalence of hepatitis C antibodies (HCV) in dialysis population at one center. Perit Dial Int 1992; 12: 28-30.
34. Knudsen F, Wantzin P, Rasmussen K et al. Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease. Kidney Int 1993; 43: 1353-56. (Pubitemid 23161424)
35. Pereira B, Levey A. Hepatitis C infection in dialysis and renal transplantation. Kidney Int 1997; 51:981-99.
36. Casio JM, Campistol JM, Dominguez-Gil B. Hepatitis C virus infection and kidney transplantation. Sem Nephrol 2002; 22: 365-74.
37. Delladetsima I, Psichogiou M, Sypsa V, et al. The course of hepatitis C virus infection in pretransplantation anti-hepatitis C virus-negative renal transplant recipients: a retrospective follow-up study. Am J Kidney Dis. 2006; 47: 309-16. (Pubitemid 43121334)
38. Corell A, Morales JM, Mandrono A, et al .Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejection. Lancet 1995; 346: 1497-8.
39. Pascual J, Crespo M, Mateos ML, et al. Reduced severity of acute rejection in hepatitis C virus positive renal allograft recipients: Are milder immunosuppressive regimens advisable? Transplant Proc 1998; 30: 1329-30.
40. Kamar N, Selves J, Sandres-Saune K, Durand D, Izopet J, Rostaing L. Does cyclosporine have a beneficial effect on the course of chronic hepatitis C infection after renal transplantation? Transplant Proc 2006; 38:1329-32.
41. Munoz De Bustillo E, Ibarrola C, Colina F et al. Fibrosing cholestatic hepatitis in hepatitis C virus-infected renal transplant recipients. J Am Soc Nephrol 1998; 9: 1109-13.
42. Pol S, Cavalcanti R, Carnot F, et al. Azathioprine hepatitis in kidney transplant recipients: A predisposing role of chronic viral hepatitis. Transplantation 1996; 61: 1774-6.
43. Zylberberg F, Carnot F, Mamzer MF et al. Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation. Transplantation 1997; 63: 158-60.
44. Kamar N, Izopet J, Ribes D, Rostaing L. Infection par le virus de l'hépatite C en transplantation rénale. Néphrologie 2004; 25: 9-15.
45. Hanafusa T, Ichikawa Y, KishikaWA H, et al. Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years. Transplantation 1998; 66: 471-6. (Pubitemid 28415373)
46. Younossi ZM, Braun WE, Protiva DA, Gifford RW, Straffon RA. Chronic viral hepatitis in renal transplant recipients with allografts functioning for more than 20 years. Transplantation 1999; 67: 272-5.